Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 311,089 $ 955,563
Short-term investments 840,378 343,248
Total cash, cash equivalents and short-term investments 1,151,467 1,298,811
Restricted cash 3,204 0
Other receivables 4,240 2,315
Prepaid expenses and other current assets 18,653 17,416
Total current assets 1,177,564 1,318,542
Property and equipment, net 61,042 53,155
Restricted cash 762 762
Equity method investment 20,144 20,306
Intangible assets 15,896 14,512
Goodwill 13,717 10,757
Other non-current assets 67,220 70,321
Total assets 1,356,345 1,488,355
Current liabilities    
Accounts payable 1,908 3,637
Accrued and other current liabilities 28,102 10,211
Total current liabilities 30,010 13,848
Stock repurchase liability 524 711
Warrant liability 31,230 44,902
Earnout Shares Liability 64,005 109,844
Other non-current liabilities 1,914 2,291
Total liabilities 127,683 171,596
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock: $0.0001 par value - 100,000,000 shares authorized at June 30, 2022 and December 31, 2021. No shares issued and outstanding at June 30, 2022 and December 31, 2021. 0 0
Common stock: $0.0001 par value - 1,400,000,000 and 1,400,000,000 shares authorized, 607,188,444 and 604,174,329 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively. 60 60
Additional paid-in capital 1,822,235 1,793,431
Accumulated deficit (588,503) (476,610)
Accumulated other comprehensive loss (5,130) (122)
Total stockholders’ equity 1,228,662 1,316,759
Total liabilities and stockholders’ equity $ 1,356,345 $ 1,488,355